Document Search

OEHHA has prepared draft hazard identification documents for the three chemicals and announces the availability of the documents for public comment:5-chloro-o-toluidine and its hydrochloride; 2,4,5-trimethylaniline and its hydrochloride; and quinoline.

Availability of the Procedure for Prioritizing Candidate Chemicals for Consideration Under Proposition 65 by the "State's Qualified Experts"

Request for information on the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Trimetrexate Glucuronate, Paclitaxel,
Quazepam, Nitrobenzene, Leuprolide Acetate, Ganciclovir Sodium, Goserelin Acetate, Estropipate, Ethionamide, Atenolol, Amiodarone Hydrochloride, C.I. Direct Blue 15, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 218, Premarin

Notice of intent to list nine chemicals via the authoritative bodies mechanism or the formally required mechanism as known to the state to cause cancer or reproductive toxicity: Nitromethane, Tetrafluoroethylene, Vinyl fluoride, Spironolactone, Stanozolol, Clarithromycin, Dihydroergotamine mesylate, Hydroxyurea, Oxymetholone

A review conducted by the Risk Assessment Advisory Committee (RAAC) with the purpose of determining if Cal/EPA risk assessment practices are based on sound science, and assessing the appropriateness of any differences in these practices with those of the US Environmental Protection Agency (US EPA), the National Academy of Sciences (NAS) and other similar bodies.

Announcement of Wednesday, December 4, 1996 meeting of the Developmental and Reproductive Toxicant Identification Committee to consider inorganic arsenic, cadmium, mechanisms for removing chemicals from the Proposition 65 list, and prioritization.

Notice of meeting of the Developmental and Reproductive Toxicant (DART) Identification Committee and draft agenda. Chemicals to be reviewed include inorganic arsenic and cadmium.

Comparative Risk Project.  One proposed way to prioritize environmental problems -- and develop viable solutions -- is through "comparative risk assessment."

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Hydrogen Cyanamide.

This final statement of reasons sets forth the reasons for the repeal of Section 12713 (Exposure to Foods, Drugs, Cosmetics, and Medical Devices) and the amendment to Section 12701 (General), and responds to the objections and recommendations submitted regarding these actions.